NM_032888.4:c.2089G>C
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP3PP5_Very_Strong
The NM_032888.4(COL27A1):c.2089G>C(p.Gly697Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000576 in 1,614,062 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_032888.4 missense
Scores
Clinical Significance
Conservation
Publications
- Steel syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL27A1 | ENST00000356083.8 | c.2089G>C | p.Gly697Arg | missense_variant | Exon 7 of 61 | 1 | NM_032888.4 | ENSP00000348385.3 | ||
| COL27A1 | ENST00000451716.5 | c.1876G>C | p.Gly626Arg | missense_variant | Exon 4 of 8 | 1 | ENSP00000391328.1 | |||
| COL27A1 | ENST00000494090.6 | n.982G>C | non_coding_transcript_exon_variant | Exon 4 of 58 | 1 | ENSP00000432928.1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152206Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251432 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461738Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727170 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000315 AC: 48AN: 152324Hom.: 1 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Steel syndrome Pathogenic:5
- -
- -
Segregates with the phenotype in an affected family -
- -
Variant summary: COL27A1 c.2089G>C (p.Gly697Arg) results in a non-conservative amino acid change located in the Collagen triple helix repeat (IPR008160) of the encoded protein sequence and disrupts a Gly residue at position 1 of a Gly-X-Y motif. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 396206 control chromosomes, predominantly at a frequency of 0.00096 within the Latino subpopulation in the gnomAD database, including 1 homozygote (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance, although studies have demonstrated that the variant of interest likely represents a founder mutation in individuals of Puerto Rican descent and that Steel syndrome can go undiagnosed (e.g., Belbin_2017). c.2089G>C has been reported in the literature in multiple homozygous individuals affected with Steel syndrome, primarily those of Puerto Rican or Hispanic/Latino descent (e.g., Gonzaga_Jauregui_2015, Belbin_2017). Additionally, individuals harboring the variant in the heterozygous state were reported to display an increased incidence of milder forms of musculoskeletal disease, including joint and spine degeneration, than non-carriers (e.g., Belbin_2017). These data indicate that the variant is very likely to be associated with autosomal recessive disease, but could lead to mild symptoms in heterozygous individuals as well. At least one publication reports experimental evidence evaluating an impact on protein function, finding that a murine model of the variant recapitulates many Steel-syndrome associated features (e.g., Gonzaga-Jauregui_2020). The following publications have been ascertained in the context of this evaluation (PMID: 28895531, 24986830, 32376988). Four submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate the variant causes abnormal collagen deposition in the extracellular matrix (Gonzaga-Jauregui et el., 2020); This variant is associated with the following publications: (PMID: 24986830, 31903681, 32376988, 28895531) -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 697 of the COL27A1 protein (p.Gly697Arg). This variant is present in population databases (rs140950220, gnomAD 0.01%). This missense change has been observed in individuals with Steel syndrome (PMID: 24986830, 31903681). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 143245). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt COL27A1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
COL27A1-related disorder Pathogenic:1
The COL27A1 c.2089G>C variant is predicted to result in the amino acid substitution p.Gly697Arg. This variant has been reported in the homozygous state in several individuals with Steel syndrome and is a well-documented as a founder variant in individuals of Puerto Rican ancestry (see for example, Gonzaga-Jauregui et al 2015. PubMed ID: 24986830; Belbin et al 2017. PubMed ID: 28895531; Amlie-Wolf et al 2020. PubMed ID: 31903681; Gonzaga-Jauregui et al 2020. PubMed ID: 32376988). This variant is reported in 0.017% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at